Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PACS Group To Contact Him Directly To Discuss Their Options Seeking Justice for Investors If you suffered losses exceeding $50,000 in PACS Group, you are not alone. Faruqi & Faruqi partner Josh Wilson is here to help…
Are You Entitled to Compensation for Purchasing Five9 Securities? Important Reminder from Rosen Law Firm New York, December 21, 2024 Hey there, savvy investors! If you’ve been following the latest news in the stock market, you may have heard about the recent reminder from Rosen Law Firm regarding Five9, Inc. securities. If you’ve purchased securities,…
Cryptocurrency Markets Experience Volatile Trading Despite Growing Interest in Spot ETFs Price Fluctuations: Cryptocurrency markets saw volatile trading on Friday with significant price movements across various digital assets. Despite growing interest in spot ETFs, the market remained unpredictable. Cryptocurrency Price Gains/Losses: Bitcoin (CRYPTO: BTC) reached $97,108.38, marking a modest increase of 0.3%. Ethereum (CRYPTO: ETH)…
Transaction in Own Shares 20 December, 2024 Shell plc Share Buy-Back Programme On 20 December 2024, Shell plc (the ‘Company’) announced that it purchased a significant number of shares for cancellation. The aggregated information on the shares purchased according to the trading venues is as follows: LSE: Date of purchase: 20/12/2024 Number of Shares purchased:…
CSP Inc. (NASDAQ: CSPI) Q4 2024 Earnings Conference Call Summary Company Participants Michael Polyviou – Investor Relations Victor Dellovo – President and Chief Executive Officer Gary Levine – Chief Financial Officer Conference Call Participants Joseph Nerges – Segren Investments Will Lauber – Visionary Wealth Advisors John Crotty – Private Investor Douglas Johnson – Private Investor…
Vivani Medical Announces First-in-Human Clinical Trial Initiation H.C. Wainwright Reiterates Buy Rating with $4 Price Target Vivani Medical, a innovative medical technology company, has recently announced the commencement of the first-in-human clinical trial for their groundbreaking product NPM-115. This exenatide implant, developed using Vivani’s NanoPortal platform technology, is set to revolutionize the treatment of certain…
Welcome to the Future of Aviation A Look at Vertical Aerospace’s Third Quarter Financial Results Hey there aviation enthusiasts! Have you heard the latest news from Vertical Aerospace Ltd.? The global aerospace and technology company just announced its financial results for the third quarter ended September 30, 2024. Exciting stuff, right? Let’s dive into the…
Get Ready for a Wild Ride with Kyverna Therapeutics: A Class Action Lawsuit Threatens to Shake Things Up Hey there, fellow investors! Buckle up, because things are about to get a little crazy in the world of Kyverna Therapeutics, Inc. If you’ve been following the news, you might have heard about the class action lawsuit…
